Patents by Inventor Gints Smits

Gints Smits has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHEMICALLY MODIFIED ENGINEERED SPIDER SILK PROTEINS
    Publication number: 20260028378
    Abstract: The present invention relates to recombinant spidroin bioconjugates (chemically modified engineered spider silk proteins). More particularly, the invention relates to recombinant spidroin bioconjugates with poly-ethyleneglycol polymers and their use in regenerative medicine.
    Type: Application
    Filed: May 26, 2022
    Publication date: January 29, 2026
    Inventors: Kristaps Jaudzems, Viktors Romanuks, Jekabs Fridmanis, Anna Lina Bula, Gints Smits
  • METABOTROPIC GLUTAMATE RECEPTOR MODULATORS
    Publication number: 20120178742
    Abstract: The invention relates to heterocyclic derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
    Type: Application
    Filed: August 3, 2010
    Publication date: July 12, 2012
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventors: Markus Henrich, Tanja Weil, Mirko Hechenberger, Sibylle Muller, Valerjans Kauss, Ronalds Zemribo, Elina Erdmane, Gints Smits